{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:50:56Z","timestamp":1789159856009,"version":"build-2803163510"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41401-023-01125-3","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T09:02:26Z","timestamp":1688720546000},"page":"2151-2168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer\u2019s disease mouse model through downregulating BACE1 and A\u03b2 generation"],"prefix":"10.1038","volume":"44","author":[{"given":"Meng-dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-fan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-rong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-shan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui-feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"731614","DOI":"10.3389\/fnins.2021.731614","volume":"15","author":"H Shi","year":"2021","unstructured":"Shi H, Koronyo Y, Rentsendorj A, Fuchs DT, Sheyn J, Black KL, et al. Retinal vasculopathy in Alzheimer\u2019s disease. Front Neurosci. 2021;15:731614.","journal-title":"Front Neurosci"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.optom.2018.07.001","volume":"12","author":"JA Fern\u00e1ndez-Albarral","year":"2019","unstructured":"Fern\u00e1ndez-Albarral JA, Salobrar-Garc\u00eda E, Mart\u00ednez-P\u00e1ramo R, Ram\u00edrez AI, de Hoz R, Ram\u00edrez JM, et al. Retinal glial changes in Alzheimer\u2019s disease - A review. J Optom. 2019;12:198\u2013207.","journal-title":"J Optom"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000440887","volume":"54","author":"MH Madeira","year":"2015","unstructured":"Madeira MH, Ambr\u00f3sio AF, Santiago AR. Glia-mediated retinal neuroinflammation as a biomarker in Alzheimer\u2019s disease. Ophthalmic Res. 2015;54:204\u201311.","journal-title":"Ophthalmic Res"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/nmt.14.19","volume":"4","author":"MH Dehabadi","year":"2014","unstructured":"Dehabadi MH, Davis BM, Wong TK, Cordeiro MF. Retinal manifestations of Alzheimer\u2019s disease. Neurodegener Dis Manag. 2014;4:241\u201352.","journal-title":"Neurodegener Dis Manag"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. NeuroImage. 2011;54:S204\u201317.","journal-title":"NeuroImage"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40035-019-0170-z","volume":"8","author":"D Georgevsky","year":"2019","unstructured":"Georgevsky D, Retsas S, Raoufi N, Shimoni O, Golzan SM. A longitudinal assessment of retinal function and structure in the APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease. Transl Neurodegener. 2019;8:30.","journal-title":"Transl Neurodegener"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fmed.2017.00203","volume":"4","author":"GAM Dolci","year":"2017","unstructured":"Dolci GAM, Damanti S, Scortichini V, Galli A, Rossi PD, Abbate C, et al. Alzheimer\u2019s disease diagnosis: discrepancy between clinical, neuroimaging, and cerebrospinal fluid biomarkers criteria in an Italian cohort of geriatric outpatients: A retrospective cross-sectional study. Front Med. 2017;4:203.","journal-title":"Front Med"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3233\/JAD-140843","volume":"42","author":"CC Tan","year":"2014","unstructured":"Tan CC, Yu JT, Tan L. Biomarkers for preclinical Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42:1051\u201369.","journal-title":"J Alzheimers Dis"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1016\/j.jalz.2014.04.015","volume":"10","author":"MS Fiandaca","year":"2014","unstructured":"Fiandaca MS, Mapstone ME, Cheema AK, Federoff HJ. The critical need for defining preclinical biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 2014;10:S196\u2013212.","journal-title":"Alzheimers Dement."},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","volume":"13","author":"S Norton","year":"2014","unstructured":"Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer\u2019s disease: An analysis of population-based data. Lancet Neurol. 2014;13:788\u201394.","journal-title":"Lancet Neurol"},{"key":"1125_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13901-z","volume":"11","author":"K Kim","year":"2020","unstructured":"Kim K, Kim MJ, Kim DW, Kim SY, Park S, Park CB. Clinically accurate diagnosis of Alzheimer\u2019s disease via multiplexed sensing of core biomarkers in human plasma. Nat Commun. 2020;11:119.","journal-title":"Nat Commun"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"e0220535","DOI":"10.1371\/journal.pone.0220535","volume":"14","author":"E Salobrar-Garc\u00eda","year":"2019","unstructured":"Salobrar-Garc\u00eda E, de Hoz R, Ram\u00edrez AI, L\u00f3pez-Cuenca I, Rojas P, Vazirani R, et al. Changes in visual function and retinal structure in the progression of Alzheimer\u2019s disease. PLoS One. 2019;14:e0220535.","journal-title":"PLoS One"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/01.wnl.0000244490.07925.8b","volume":"67","author":"HV Danesh-Meyer","year":"2006","unstructured":"Danesh-Meyer HV, Birch H, Ku JY, Carroll S, Gamble G. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology. 2006;67:1852\u20134.","journal-title":"Neurology"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/awp062","volume":"132","author":"CR Jack Jr.","year":"2009","unstructured":"Jack CR Jr., Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: implications for sequence of pathological events in Alzheimer\u2019s disease. Brain. 2009;132:1355\u201365.","journal-title":"Brain"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12:357\u201367.","journal-title":"Lancet Neurol"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","volume":"11","author":"EM Reiman","year":"2012","unstructured":"Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol. 2012;11:1048\u201356.","journal-title":"Lancet Neurol"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"597491","DOI":"10.3389\/fnagi.2020.597491","volume":"12","author":"A Zhao","year":"2020","unstructured":"Zhao A, Fang F, Li B, Chen Y, Qiu Y, Wu Y, et al. Visual abnormalities associate with hippocampus in mild cognitive impairment and early Alzheimer\u2019s disease. Front Aging Neurosci. 2020;12:597491.","journal-title":"Front Aging Neurosci"},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 2016;79:90\u2013109.","journal-title":"Ann Neurol"},{"key":"1125_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01094-2","volume":"8","author":"RJ Bevan","year":"2020","unstructured":"Bevan RJ, Hughes TR, Williams PA, Good MA, Morgan BP, Morgan JE. Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer\u2019s disease. Acta Neuropathol Commun. 2020;8:216.","journal-title":"Acta Neuropathol Commun"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2007.02.090","volume":"420","author":"C Paquet","year":"2007","unstructured":"Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurosci Lett. 2007;420:97\u20139.","journal-title":"Neurosci Lett"},{"key":"1125_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","volume":"60","author":"L Gao","year":"2015","unstructured":"Gao L, Liu Y, Li X, Bai Q, Liu P. Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer\u2019s disease. Arch Gerontol Geriatr. 2015;60:162\u20137.","journal-title":"Arch Gerontol Geriatr"},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"681831","DOI":"10.3389\/fnins.2021.681831","volume":"15","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhong L, Han X, Xiong G, Xu D, Zhang S, et al. Brain and retinal abnormalities in the 5xFAD mouse model of Alzheimer\u2019s disease at early stages. Front Neurosci. 2021;15:681831.","journal-title":"Front Neurosci"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","volume":"14","author":"JKH Lim","year":"2020","unstructured":"Lim JKH, Li QX, He Z, Vingrys AJ, Chinnery HR, Mullen J, et al. Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer\u2019s disease. Front Neurosci. 2020;14:862.","journal-title":"Front Neurosci"},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-010-0762-2","volume":"121","author":"V Dinet","year":"2011","unstructured":"Dinet V, An N, Ciccotosto GD, Bruban J, Maoui A, Bellingham SA, et al. APP involvement in retinogenesis of mice. Acta Neuropathol. 2011;121:351\u201363.","journal-title":"Acta Neuropathol"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1167\/iovs.08-1849","volume":"49","author":"A Ning","year":"2008","unstructured":"Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci. 2008;49:5136\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1125_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1167\/iovs.08-2384","volume":"50","author":"SE Perez","year":"2009","unstructured":"Perez SE, Lumayag S, Kovacs B, Mufson EJ, Xu S. Beta-amyloid deposition and functional impairment in the retina of the APPswe\/PS1DeltaE9 transgenic mouse model of Alzheimer\u2019s disease. Investigative Ophthalmol Vis Sci. 2009;50:793\u2013800.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"1125_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.exer.2014.08.006","volume":"127","author":"MM Edwards","year":"2014","unstructured":"Edwards MM, Rodr\u00edguez JJ, Gutierrez-Lanza R, Yates J, Verkhratsky A, Lutty GA. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer\u2019s disease. Exp Eye Res. 2014;127:252\u201360.","journal-title":"Exp Eye Res"},{"key":"1125_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0740-5","volume":"9","author":"A Grimaldi","year":"2018","unstructured":"Grimaldi A, Brighi C, Peruzzi G, Ragozzino D, Bonanni V, Limatola C, et al. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer\u2019s disease in the 3xTg-AD mouse model. Cell Death Dis. 2018;9:685.","journal-title":"Cell Death Dis"},{"key":"1125_CR29","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2353\/ajpath.2009.090159","volume":"175","author":"B Liu","year":"2009","unstructured":"Liu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J, et al. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer\u2019s transgenic mice. Am J Pathol. 2009;175:2099\u2013110.","journal-title":"Am J Pathol"},{"key":"1125_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/jop.2016.0180","volume":"34","author":"L De Groef","year":"2018","unstructured":"De Groef L, Cordeiro MF. Is the eye an extension of the brain in central nervous system disease? J Ocul Pharmacol Ther. 2018;34:129\u201333.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1125_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00401-016-1628-z","volume":"132","author":"MF Cordeiro","year":"2016","unstructured":"Cordeiro MF. Eyeing the brain. Acta Neuropathol. 2016;132:765\u20136.","journal-title":"Acta Neuropathol"},{"key":"1125_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9:44\u201353.","journal-title":"Nat Rev Neurol"},{"key":"1125_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/EB.S235238","volume":"13","author":"A Song","year":"2021","unstructured":"Song A, Johnson N, Ayala A, Thompson AC. Optical coherence tomography in patients with Alzheimer\u2019s disease: what can it tell us? Eye Brain. 2021;13:1\u201320.","journal-title":"Eye Brain"},{"key":"1125_CR34","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10792-014-0004-z","volume":"34","author":"SA Kurna","year":"2014","unstructured":"Kurna SA, Akar G, Altun A, Agirman Y, Gozke E, Sengor T. Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer\u2019s disease compared to glaucoma and control. Int Ophthalmol. 2014;34:1203\u201311.","journal-title":"Int Ophthalmol"},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1007\/s12035-018-1461-6","volume":"56","author":"S Chiquita","year":"2019","unstructured":"Chiquita S, Rodrigues-Neves AC, Baptista FI, Carecho R, Moreira PI, Castelo-Branco M, et al. The retina as a window or mirror of the brain changes detected in Alzheimer\u2019s disease: Critical aspects to unravel. Mol Neurobiol. 2019;56:5416\u201335.","journal-title":"Mol Neurobiol"},{"key":"1125_CR36","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.preteyeres.2020.100899","volume":"82","author":"VB Gupta","year":"2021","unstructured":"Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, et al. Retinal changes in Alzheimer\u2019s disease- integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res. 2021;82:100899.","journal-title":"Prog Retin Eye Res"},{"key":"1125_CR37","doi-asserted-by":"publisher","first-page":"788798","DOI":"10.3389\/fnagi.2021.788798","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Baum L, Yu S, Lin Y, Xiong G, Chang RC, et al. Preservation of retinal function through synaptic stabilization in Alzheimer\u2019s disease model mouse retina by Lycium Barbarum extracts. Front Aging Neurosci. 2021;13:788798.","journal-title":"Front Aging Neurosci"},{"key":"1125_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10295-015-1723-5","volume":"43","author":"L Katz","year":"2016","unstructured":"Katz L, Baltz RH. Natural product discovery: past, present, and future. J Ind Microbiol Biotechnol. 2016;43:155\u201376.","journal-title":"J Ind Microbiol Biotechnol"},{"key":"1125_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/1673-5374.314325","volume":"17","author":"ZQ Sun","year":"2022","unstructured":"Sun ZQ, Liu JF, Luo W, Wong CH, So KF, Hu Y, et al. Lycium barbarum extract promotes M2 polarization and reduces oligomeric amyloid-beta-induced inflammatory reactions in microglial cells. Neural Regen Res. 2022;17:203\u20139.","journal-title":"Neural Regen Res"},{"key":"1125_CR40","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/alz.12258","volume":"17","author":"S Li","year":"2021","unstructured":"Li S, Wu Z, Le W. Traditional Chinese medicine for dementia. Alzheimers Dement. 2021;17:1066\u201371.","journal-title":"Alzheimers Dement"},{"key":"1125_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejphar.2013.02.015","volume":"704","author":"YW Lee","year":"2013","unstructured":"Lee YW, Kim DH, Jeon SJ, Park SJ, Kim JM, Jung JM, et al. Neuroprotective effects of salvianolic acid B on an A\u03b225-35 peptide-induced mouse model of Alzheimer\u2019s disease. Eur J Pharmacol. 2013;704:70\u20137.","journal-title":"Eur J Pharmacol"},{"key":"1125_CR42","doi-asserted-by":"publisher","first-page":"114389","DOI":"10.1016\/j.jep.2021.114389","volume":"279","author":"FHP Tan","year":"2021","unstructured":"Tan FHP, Ting ACJ, Leow BG, Najimudin N, Watanabe N, Azzam G. Alleviatory effects of Danshen, Salvianolic acid A and Salvianolic acid B on PC12 neuronal cells and Drosophila melanogaster model of Alzheimer\u2019s disease. J Ethnopharmacol. 2021;279:114389.","journal-title":"J Ethnopharmacol"},{"key":"1125_CR43","first-page":"e12742","volume":"43","author":"Q Huang","year":"2019","unstructured":"Huang Q, Ye X, Wang L, Pan J. Salvianolic acid B abolished chronic mild stress-induced depression through suppressing oxidative stress and neuro-inflammation via regulating NLRP3 inflammasome activation. J Food Biochem. 2019;43:e12742.","journal-title":"J Food Biochem"},{"key":"1125_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/JIR.S249363","volume":"13","author":"D Liao","year":"2020","unstructured":"Liao D, Chen Y, Guo Y, Wang C, Liu N, Gong Q, et al. Salvianolic Acid B improves chronic mild stress-induced depressive behaviors in rats: Involvement of AMPK\/SIRT1 Signaling Pathway. J Inflamm Res. 2020;13:195\u2013206.","journal-title":"J Inflamm Res"},{"key":"1125_CR45","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/aps.2016.63","volume":"37","author":"JQ Zhang","year":"2016","unstructured":"Zhang JQ, Wu XH, Feng Y, Xie XF, Fan YH, Yan S, et al. Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: involvement of the neuroinflammatory pathway. Acta Pharmacol Sin. 2016;37:1141\u201353.","journal-title":"Acta Pharmacol Sin"},{"key":"1125_CR46","doi-asserted-by":"publisher","first-page":"e101668","DOI":"10.1371\/journal.pone.0101668","volume":"9","author":"J Zhou","year":"2014","unstructured":"Zhou J, Qu XD, Li ZY, Wei J, Liu Q, Ma YH, et al. Salvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson\u2019s disease models. PLoS One. 2014;9:e101668.","journal-title":"PLoS One"},{"key":"1125_CR47","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/WNR.0000000000001660","volume":"32","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhang Y, Zhang J, Yang G. Salvianolic acid B protects against MPP+-induced neuronal injury via repressing oxidative stress and restoring mitochondrial function. Neuroreport. 2021;32:815\u201323.","journal-title":"Neuroreport"},{"key":"1125_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2017.07.012","volume":"66","author":"J Zhang","year":"2017","unstructured":"Zhang J, Xie X, Tang M, Zhang J, Zhang B, Zhao Q, et al. Salvianolic acid B promotes microglial M2-polarization and rescues neurogenesis in stress-exposed mice. Brain Behav Immun. 2017;66:111\u201324.","journal-title":"Brain Behav Immun"},{"key":"1125_CR49","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.18632\/aging.103306","volume":"12","author":"J Liu","year":"2020","unstructured":"Liu J, Wang Y, Guo J, Sun J, Sun Q. Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing A\u03b2 level in Porphyromonas gingivalis-infected mice. Aging. 2020;12:10117\u201328.","journal-title":"Aging"},{"key":"1125_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1013-4","volume":"14","author":"P Jiang","year":"2017","unstructured":"Jiang P, Guo Y, Dang R, Yang M, Liao D, Li H, et al. Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome. J Neuroinflamm. 2017;14:239.","journal-title":"J Neuroinflamm"},{"key":"1125_CR51","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.neuint.2007.09.006","volume":"52","author":"SS Durairajan","year":"2008","unstructured":"Durairajan SS, Yuan Q, Xie L, Chan WS, Kum WF, Koo I, et al. Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty. Neurochem. Int. 2008;52:741\u201350.","journal-title":"Neurochem. Int"},{"key":"1125_CR52","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbrc.2006.07.110","volume":"348","author":"YH Lin","year":"2006","unstructured":"Lin YH, Liu AH, Wu HL, Westenbroek C, Song QL, Yu HM, et al. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Abeta(25-35)-induced reduction in BPRP in PC12 cells. Biochem Biophys Res Commun. 2006;348:593\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"1125_CR53","first-page":"1704","volume":"39","author":"SM Liu","year":"2014","unstructured":"Liu SM, Yang ZH, Sun XB. Simultaneous determination of six Salvia miltiorrhiza gradients in rat plasma and brain by LC-MS\/MS. China J Chin Mater Med. 2014;39:1704\u20138.","journal-title":"China J Chin Mater Med"},{"key":"1125_CR54","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.1523\/JNEUROSCI.5200-13.2014","volume":"34","author":"B Peng","year":"2014","unstructured":"Peng B, Xiao J, Wang K, So KF, Tipoe GL, Lin B. Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa. J Neurosci. 2014;34:8139\u201350.","journal-title":"J Neurosci"},{"key":"1125_CR55","doi-asserted-by":"crossref","unstructured":"Zheng Q, Li G, Wang S, Zhou Y, Liu K, Gao Y, et al. Trisomy 21-induced dysregulation of microglial homeostasis in Alzheimer\u2019s brains is mediated by USP25. Sci Adv. 2021;7:eabe1340.","DOI":"10.1126\/sciadv.abe1340"},{"key":"1125_CR56","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1083\/jcb.201105109","volume":"195","author":"L Wen","year":"2011","unstructured":"Wen L, Tang FL, Hong Y, Luo SW, Wang CL, He W, et al. VPS35 haploinsufficiency increases Alzheimer\u2019s disease neuropathology. J Cell Biol. 2011;195:765\u201379.","journal-title":"J Cell Biol"},{"key":"1125_CR57","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1073\/pnas.0910302107","volume":"107","author":"L Wen","year":"2010","unstructured":"Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ, et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA. 2010;107:1211\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1125_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09118-9","volume":"10","author":"L Zhong","year":"2019","unstructured":"Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model. Nat Commun. 2019;10:1365.","journal-title":"Nat Commun"},{"key":"1125_CR59","doi-asserted-by":"crossref","unstructured":"Zheng Q, Song B, Li G, Cai F, Wu M, Zhao Y, et al. USP25 inhibition ameliorates Alzheimer\u2019s pathology through the regulation of APP processing and A\u03b2 generation. J Clin Invest. 2022;132:e152170.","DOI":"10.1172\/JCI152170"},{"key":"1125_CR60","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-\u03b2 metabolism beyond the brain. Nat Rev Neurol. 2017;13:612\u201323.","journal-title":"Nat Rev Neurol"},{"key":"1125_CR61","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-160907","volume":"57","author":"FT Hane","year":"2017","unstructured":"Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS. Recent progress in Alzheimer\u2019s disease research, Part 3: diagnosis and treatment. J Alzheimers Dis. 2017;57:645\u201365.","journal-title":"J Alzheimers Dis"},{"key":"1125_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-160882","volume":"57","author":"FT Hane","year":"2017","unstructured":"Hane FT, Lee BY, Leonenko Z. Recent progress in Alzheimer\u2019s disease research, Part 1: Pathology. J Alzheimer\u2019s Dis. 2017;57:1\u201328.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1125_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/JAD-161149","volume":"57","author":"M Robinson","year":"2017","unstructured":"Robinson M, Lee BY, Hane FT. Recent progress in Alzheimer\u2019s disease research, Part 2: Genetics and Epidemiology. J Alzheimers Dis. 2017;57:317\u201330.","journal-title":"J Alzheimers Dis"},{"key":"1125_CR64","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Prim. 2015;1:15056.","journal-title":"Nat Rev Dis Prim"},{"key":"1125_CR65","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fnins.2020.00921","volume":"14","author":"N Mirzaei","year":"2020","unstructured":"Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs DT, et al. Alzheimer\u2019s retinopathy: seeing disease in the eyes. Front Neurosci. 2020;14:921.","journal-title":"Front Neurosci"},{"key":"1125_CR66","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fnins.2016.00536","volume":"10","author":"JK Lim","year":"2016","unstructured":"Lim JK, Li QX, He Z, Vingrys AJ, Wong VH, Currier N, et al. The eye as a biomarker for Alzheimer\u2019s disease. Front Neurosci. 2016;10:536.","journal-title":"Front Neurosci"},{"key":"1125_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-017-0239-9","volume":"9","author":"SM Golzan","year":"2017","unstructured":"Golzan SM, Goozee K, Georgevsky D, Avolio A, Chatterjee P, Shen K, et al. Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9:13.","journal-title":"Alzheimers Res Ther"},{"key":"1125_CR68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1469-7580.2005.00395.x","volume":"206","author":"N Patton","year":"2005","unstructured":"Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005;206:319\u201348.","journal-title":"J Anat"},{"key":"1125_CR69","doi-asserted-by":"publisher","first-page":"600084","DOI":"10.3389\/fnmol.2020.600084","volume":"13","author":"A Hector","year":"2020","unstructured":"Hector A, Brouillette J. Hyperactivity induced by soluble Amyloid-\u03b2 oligomers in the early stages of Alzheimer\u2019s disease. Front Mol Neurosci. 2020;13:600084.","journal-title":"Front Mol Neurosci"},{"key":"1125_CR70","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jinorgbio.2015.07.009","volume":"152","author":"AI Pogue","year":"2015","unstructured":"Pogue AI, Dua P, Hill JM, Lukiw WJ. Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice. J Inorg Biochem. 2015;152:206\u20139.","journal-title":"J Inorg Biochem"},{"key":"1125_CR71","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature16468","volume":"529","author":"T Baden","year":"2016","unstructured":"Baden T, Berens P, Franke K, Rom\u00e1n Ros\u00f3n M, Bethge M, Euler T. The functional diversity of retinal ganglion cells in the mouse. Nature. 2016;529:345\u201350.","journal-title":"Nature"},{"key":"1125_CR72","first-page":"54","volume":"35","author":"BM Dow","year":"1976","unstructured":"Dow BM. Central mechanisms of vision: parallel processing. Fed Proc. 1976;35:54\u20139.","journal-title":"Fed Proc"},{"key":"1125_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-015-0561-1","volume":"15","author":"HE Moss","year":"2015","unstructured":"Moss HE. Retinal vascular changes are a marker for cerebral vascular diseases. Curr Neurol Neurosci Rep. 2015;15:40.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1125_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","volume":"51","author":"E Vecino","year":"2016","unstructured":"Vecino E, Rodriguez FD, Ruzafa N, Pereiro X, Sharma SC. Glia-neuron interactions in the mammalian retina. Prog Retin Eye Res. 2016;51:1\u201340.","journal-title":"Prog Retin Eye Res"},{"key":"1125_CR75","doi-asserted-by":"crossref","unstructured":"Yu DY, Cringle SJ, Yu PK, Su EN, Sun X, Guo W, et al. Retinal cellular metabolism and its regulation and control. In: Maiese K, editor. Neurovascular Medicine: Pursuing Cellular Longevity for Healthy Aging. Oxford: Oxford University Press; 2009.","DOI":"10.1093\/acprof:oso\/9780195326697.003.0004"},{"key":"1125_CR76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0166-2236(00)02028-2","volume":"25","author":"T Marquardt","year":"2002","unstructured":"Marquardt T, Gruss P. Generating neuronal diversity in the retina: One for nearly all. Trends Neurosci. 2002;25:32\u20138.","journal-title":"Trends Neurosci"},{"key":"1125_CR77","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.neuron.2014.08.054","volume":"83","author":"HS Seung","year":"2014","unstructured":"Seung HS, S\u00fcmb\u00fcl U. Neuronal cell types and connectivity: Lessons from the retina. Neuron. 2014;83:1262\u201372.","journal-title":"Neuron"},{"key":"1125_CR78","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0959-4388(00)00230-0","volume":"11","author":"RH Masland","year":"2001","unstructured":"Masland RH. Neuronal diversity in the retina. Curr Opin Neurobiol. 2001;11:431\u20136.","journal-title":"Curr Opin Neurobiol"},{"key":"1125_CR79","doi-asserted-by":"publisher","first-page":"83038","DOI":"10.18632\/oncotarget.19886","volume":"8","author":"L Buccarello","year":"2017","unstructured":"Buccarello L, Sclip A, Sacchi M, Castaldo AM, Bertani I, ReCecconi A, et al. The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies. Oncotarget. 2017;8:83038\u201351.","journal-title":"Oncotarget"},{"key":"1125_CR80","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2018.03.017","volume":"67","author":"C Criscuolo","year":"2018","unstructured":"Criscuolo C, Cerri E, Fabiani C, Capsoni S, Cattaneo A, Domenici L. The retina as a window to early dysfunctions of Alzheimer\u2019s disease following studies with a 5xFAD mouse model. Neurobiol Aging. 2018;67:181\u20138.","journal-title":"Neurobiol Aging"},{"key":"1125_CR81","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13195-019-0542-8","volume":"11","author":"S Chiquita","year":"2019","unstructured":"Chiquita S, Campos EJ, Castelhano J, Ribeiro M, Sereno J, Moreira PI, et al. Retinal thinning of inner sub-layers is associated with cortical atrophy in a mouse model of Alzheimer\u2019s disease: a longitudinal multimodal in vivo study. Alzheimers Res Ther. 2019;11:90.","journal-title":"Alzheimers Res Ther"},{"key":"1125_CR82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2016.04.059","volume":"623","author":"VK Gupta","year":"2016","unstructured":"Gupta VK, Chitranshi N, Gupta VB, Golzan M, Dheer Y, Wall RV, et al. Amyloid \u03b2 accumulation and inner retinal degenerative changes in Alzheimer\u2019s disease transgenic mouse. Neurosci Lett. 2016;623:52\u20136.","journal-title":"Neurosci Lett"},{"key":"1125_CR83","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci. 2011;34:185\u2013204.","journal-title":"Annu Rev Neurosci"},{"key":"1125_CR84","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1471-4159.2011.07623.x","volume":"120","author":"J Tan","year":"2012","unstructured":"Tan J, Evin G. \u0392-site APP-cleaving enzyme 1 trafficking and Alzheimer\u2019s disease pathogenesis. J Neurochem. 2012;120:869\u201380.","journal-title":"J Neurochem"},{"key":"1125_CR85","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4103\/1673-5374.179068","volume":"11","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Ding L, Qiu WF, Wu HF, Li R. Salvianolic acid B protects the myelin sheath around injured spinal cord axons. Neural Regen Res. 2016;11:487\u201392.","journal-title":"Neural Regen Res"},{"key":"1125_CR86","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-vision-091517-034425","volume":"4","author":"SM Silverman","year":"2018","unstructured":"Silverman SM, Wong WT. Microglia in the retina: roles in development, maturity, and disease. Annu Rev Vis Sci. 2018;4:45\u201377.","journal-title":"Annu Rev Vis Sci"},{"key":"1125_CR87","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s11064-010-0151-1","volume":"35","author":"SX Wang","year":"2010","unstructured":"Wang SX, Hu LM, Gao XM, Guo H, Fan GW. Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect. Neurochem Res. 2010;35:1029\u201337.","journal-title":"Neurochem Res"},{"key":"1125_CR88","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.biocel.2007.08.005","volume":"40","author":"LL Tian","year":"2008","unstructured":"Tian LL, Wang XJ, Sun YN, Li CR, Xing YL, Zhao HB, et al. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol. 2008;40:409\u201322.","journal-title":"Int J Biochem Cell Biol"},{"key":"1125_CR89","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbrc.2018.03.119","volume":"498","author":"Y He","year":"2018","unstructured":"He Y, Jia K, Li L, Wang Q, Zhang S, Du J, et al. Salvianolic acid B attenuates mitochondrial stress against A\u03b2 toxicity in primary cultured mouse neurons. Biochem Biophys Res Commun. 2018;498:1066\u201372.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01125-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T09:04:23Z","timestamp":1698743063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-023-01125-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":89,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1038\/s41401-023-01125-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"28 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}